Behavioral and molecular changes in the mouse in response to prenatal exposure to the anti-epileptic drug valproic acid

Neuroscience

Volumn 170, Issue 2, 2010, Pages 514-522

  Roullet, F I ^a,b   Wollaston, L ^a,b   deCatanzaro, D ^a   Foster, J A ^a,b  

^a MCMASTER UNIVERSITY   (Canada)

^b Brain Body Institute   (Canada)

Author keywords

Brain derived neurotrophic factor; Gene expression; In situ hybridization; Social behavior; Valproic acid

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTISM; BEHAVIOR DISORDER; BRAIN TISSUE; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; FEMALE; GENE EXPRESSION; IN SITU HYBRIDIZATION; LOCOMOTION; MOUSE; NERVE CELL PLASTICITY; NEUROTOXICITY; NEWBORN; NONHUMAN; OLFACTORY DISCRIMINATION; PHENOTYPE; PHYSICAL DEVELOPMENT; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMELLING DISORDER; SOCIAL BEHAVIOR;

ANIMALS; ANTICONVULSANTS; AUTISTIC DISORDER; BEHAVIOR, ANIMAL; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; MALE; MICE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RECEPTORS, N-METHYL-D-ASPARTATE; VALPROIC ACID;

EID: 77956184210     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.06.069     Document Type: Article

References (76)

1. Adolphs R. The neurobiology of social cognition. Curr Opin Neurobiol 2001, 11:231-239.
2. Adrien J.L., Perrot A., Sauvage D., Leddet I., Larmande C., Hameury L., Barthelemy C. Early symptoms in autism from family home movies. Evaluation and comparison between 1st and 2nd year of life using. I.B.S.E. scale. Acta Paedopsychiatr 1992, 55:71-75.
3. Altschul S.F., Gish W., Miller W., Myers E.W., Lipman D.J. Basic local alignment search tool. J Mol Biol 1990, 215:403-410.
4. Anderson G.M., Gutknecht L., Cohen D.J., Brailly-Tabard S., Cohen J.H., Ferrari P., Roubertoux P.L., Tordjman S. Serotonin transporter promoter variants in autism: functional effects and relationship to platelet hyperserotonemia. Mol Psychiatry 2002, 7:831-836.
5. Branchi I., D'Andrea I., Fiore M., Di Fausto V., Aloe L., Alleva E. Early social enrichment shapes social behavior and nerve growth factor and brain-derived neurotrophic factor levels in the adult mouse brain. Biol Psychiatry 2006, 60:690-696.
6. Branchi I., D'Andrea I., Sietzema J., Fiore M., Di Fausto V., Aloe L., Alleva E. Early social enrichment augments adult hippocampal BDNF levels and survival of BrdU-positive cells while increasing anxiety-and "depression"-like behavior. J Neurosci Res 2006, 83:965-973.
7. Bromley R.L., Mawer G., Clayton-Smith J., Baker G.A. Autism spectrum disorders following in utero exposure to antiepileptic drugs. Neurology 2008, 71:1923-1924.
8. Bruno J.P., Teicher M.H., Blass E.M. Sensory determinants of suckling behavior in weanling rats. J Comp Physiol Psychol 1980, 94:115-127.
9. Chess S., Fernandez P., Korn S. Behavioral consequences of congenital rubella. J Pediatr 1978, 93:699-703.
10. Chez M.G., Burton Q., Dowling T., Chang M., Khanna P., Kramer C. Memantine as adjunctive therapy in children diagnosed with autistic spectrum disorders: an observation of initial clinical response and maintenance tolerability. J Child Neurol 2007, 22:574-579.
11. Christianson A.L., Chesler N., Kromberg J.G. Fetal valproate syndrome: clinical and neuro-developmental features in two sibling pairs. Dev Med Child Neurol 1994, 36:361-369.
12. Crawley J.N. Designing mouse behavioral tasks relevant to autistic-like behaviors. Ment Retard Dev Disabil Res Rev 2004, 10:248-258.
13. Dean J.C., Hailey H., Moore S.J., Lloyd D.J., Turnpenny P.D., Little J. Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth. J Med Genet 2002, 39:251-259.
14. deCatanzaro D., Zacharias R., Muir C. Disruption of early pregnancy by direct and indirect exposure to novel males in mice: comparison of influences of preputialectomized and intact males. J Reprod Fertil 1996, 106:269-274.
15. DiCicco-Bloom E., Lord C., Zwaigenbaum L., Courchesne E., Dager S.R., Schmitz C., Schultz R.T., Crawley J., Young L.J. The developmental neurobiology of autism spectrum disorder. J Neurosci 2006, 26:6897-6906.
16. Dufour-Rainfray D., Vourch P., Le Guisquet A.M., Garreau L., Ternant D., Bodard S., Jaumain E., Gulhan Z., Belzung C., Andres C.R., Chalon S., Guilloteau D. Behavior and serotonergic disorders in rats exposed prenatally to valproate: a model for autism. Neurosci Lett 2010, 470:55-59.
17. Engesser-Cesar C., Anderson A.J., Cotman C.W. Wheel running and fluoxetine antidepressant treatment have differential effects in the hippocampus and the spinal cord. Neuroscience 2007, 144:1033-1044.
18. Fillion T.J., Blass E.M. Infantile experience with suckling odors determines adult sexual behavior in male rats. Science 1986, 231:729-731.
19. Fombonne E. Epidemiological trends in rates of autism. Mol Psychiatry 2002, 7(Suppl 2):S4-S6.
20. Fombonne E. Epidemiological surveys of autism and other pervasive developmental disorders: an update. J Autism Dev Disord 2003, 33:365-382.
21. Foster J.A., Quan N., Stern E.L., Kristensson K., Herkenham M. Induced neuronal expression of class I major histocompatibility complex mRNA in acute and chronic inflammation models. J Neuroimmunol 2002, 131:83-91.
22. Frith U., Happe F. Language and communication in autistic disorders. Philos Trans R Soc Lond B Biol Sci 1994, 346:97-104.
23. Haddad P.M., Das A., Ashfaq M., Wieck A. A review of valproate in psychiatric practice. Expert Opin Drug Metab Toxicol 2009, 5:539-551.
24. Hashimoto K., Iwata Y., Nakamura K., Tsujii M., Tsuchiya K.J., Sekine Y., Suzuki K., Minabe Y., Takei N., Iyo M., Mori N. Reduced serum levels of brain-derived neurotrophic factor in adult male patients with autism. Prog Neuropsychopharmacol Biol Psychiatry 2006, 30:1529-1531.
25. Hertz-Picciotto I., Croen L.A., Hansen R., Jones C.R., van de Water J., Pessah I.N. The CHARGE study: an epidemiologic investigation of genetic and environmental factors contributing to autism. Environ Health Perspect 2006, 114:1119-1125.
26. Hollander E., Phillips A., Chaplin W., Zagursky K., Novotny S., Wasserman S., Iyengar R. A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism. Neuropsychopharmacology 2005, 30:582-589.
27. Huang Q., Liu D., Majewski P., Schulte L.C., Korn J.M., Young R.A., Lander E.S., Hacohen N. The plasticity of dendritic cell responses to pathogens and their components. Science 2001, 294:870-875.
28. Ingram J.L., Peckham S.M., Tisdale B., Rodier P.M. Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism. Neurotoxicol Teratol 2000, 22:319-324.
29. Jamain S., Quach H., Betancur C., Rastam M., Colineaux C., Gillberg I.C., Soderstrom H., Giros B., Leboyer M., Gillberg C., Bourgeron T. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet 2003, 34:27-29.
30. Jeon G.S., Park S.H., Lee K.J., Lee M.S., Chun B.G., Shin K.H. Valproate prevents MK801-induced changes in brain-derived neurotrophic factor mRNA in the rat brain. Eur J Pharmacol 2006, 545:142-146.
31. Katoh-Semba R., Wakako R., Komori T., Shigemi H., Miyazaki N., Ito H., Kumagai T., Tsuzuki M., Shigemi K., Yoshida F., Nakayama A. Age-related changes in BDNF protein levels in human serum: differences between autism cases and normal controls. Int J Dev Neurosci 2007, 25:367-372.
32. Kolozsi E., Mackenzie R.N., Roullet F.I., deCatanzaro D., Foster J.A. Prenatal exposure to valproic acid leads to reduced expression of synaptic adhesion molecule neuroligin 3 in mice. Neuroscience 2009, 163:1201-1210.
33. Landa R. Early communication development and intervention for children with autism. Ment Retard Dev Disabil Res Rev 2007, 13:16-25.
34. Lein E.S., Hawrylycz M.J., Ao N., Ayres M., Bensinger A., Bernard A., Boe A.F., Boguski M.S., Brockway K.S., Byrnes E.J., Chen L., Chen L., Chen T.M., Chin M.C., Chong J., Crook B.E., Czaplinska A., Dang C.N., Datta S., Dee N.R., Desaki A.L., Desta T., Diep E., Dolbeare T.A., Donelan M.J., Dong H.W., Dougherty J.G., Duncan B.J., Ebbert A.J., Eichele G., Estin L.K., Faber C., Facer B.A., Fields R., Fischer S.R., Fliss T.P., Frensley C., Gates S.N., Glattfelder K.J., Halverson K.R., Hart M.R., Hohmann J.G., Howell M.P., Jeung D.P., Johnson R.A., Karr P.T., Kawal R., Kidney J.M., Knapik R.H., Kuan C.L., Lake J.H., Laramee A.R., Larsen K.D., Lau C., Lemon T.A., Liang A.J., Liu Y., Luong L.T., Michaels J., Morgan J.J., Morgan R.J., Mortrud M.T., Mosqueda N.F., Ng L.L., Ng R., Orta G.J., Overly C.C., Pak T.H., Parry S.E., Pathak S.D., Pearson O.C., Puchalski R.B., Riley Z.L., Rockett H.R., Rowland S.A., Royall J.J., Ruiz M.J., Sarno N.R., Schaffnit K., Shapovalova N.V., Sivisay T., Slaughterbeck C.R., Smith S.C., Smith K.A., Smith B.I., Sodt A.J., Stewart N.N., Stumpf K.R., Sunkin S.M., Sutram M., Tam A., Teemer C.D., Thaller C., Thompson C.L., Varnam L.R., Visel A., Whitlock R.M., Wohnoutka P.E., Wolkey C.K., Wong V.Y., Wood M., Yaylaoglu M.B., Young R.C., Youngstrom B.L., Yuan X.F., Zhang B., Zwingman T.A., Jones A.R. Genome-wide atlas of gene expression in the adult mouse brain. Nature 2007, 445:168-176.
35. Lord C., Leventhal B.L., Cook E.H. Quantifying the phenotype in autism spectrum disorders. Am J Med Genet 2001, 105:36-38.
36. Lord C., Risi S., DiLavore P.S., Shulman C., Thurm A., Pickles A. Autism from 2 to 9 years of age. Arch Gen Psychiatry 2006, 63:694-701.
37. Markram K., Rinaldi T., La Mendola D., Sandi C., Markram H. Abnormal fear conditioning and amygdala processing in an animal model of autism. Neuropsychopharmacology 2008, 33:901-912.
38. Martinowich K., Lu B. Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacology 2008, 33:73-83.
39. Martinowich K., Manji H., Lu B. New insights into BDNF function in depression and anxiety. Nat Neurosci 2007, 10:1089-1093.
40. McKinney W.T., Bunney W.E. Animal model of depression. I. Review of evidence: implications for research. Arch Gen Psychiatry 1969, 21:240-248.
41. Melo A.I., Lovic V., Gonzalez A., Madden M., Sinopoli K., Fleming A.S. Maternal and littermate deprivation disrupts maternal behavior and social-learning of food preference in adulthood: tactile stimulation, nest odor, and social rearing prevent these effects. Dev Psychobiol 2006, 48:209-219.
42. Miyazaki K., Narita N., Sakuta R., Miyahara T., Naruse H., Okado N., Narita M. Serum neurotrophin concentrations in autism and mental retardation: a pilot study. Brain Dev 2004, 26:292-295.
43. Moore S.J., Turnpenny P., Quinn A., Glover S., Lloyd D.J., Montgomery T., Dean J.C. A clinical study of 57 children with fetal anticonvulsant syndromes. J Med Genet 2000, 37:489-497.
44. Moy S.S., Nadler J.J., Perez A., Barbaro R.P., Johns J.M., Magnuson T.R., Piven J., Crawley J.N. Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes Brain Behav 2004, 3:287-302.
45. Nadel S., Poss J.E. Early detection of autism spectrum disorders: screening between 12 and 24 months of age. J Am Acad Nurse Pract 2007, 19:408-417.
46. Nakasato A., Nakatani Y., Seki Y., Tsujino N., Umino M., Arita H. Swim stress exaggerates the hyperactive mesocortical dopamine system in a rodent model of autism. Brain Res 2008, 1193:128-135.
47. Narita N., Kato M., Tazoe M., Miyazaki K., Narita M., Okado N. Increased monoamine concentration in the brain and blood of fetal thalidomide- and valproic acid-exposed rat: putative animal models for autism. Pediatr Res 2002, 52:576-579.
48. Nelson K.B., Grether J.K., Croen L.A., Dambrosia J.M., Dickens B.F., Jelliffe L.L., Hansen R.L., Phillips T.M. Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation. Ann Neurol 2001, 49:597-606.
49. Nishimura K., Nakamura K., Anitha A., Yamada K., Tsujii M., Iwayama Y., Hattori E., Toyota T., Takei N., Miyachi T., Iwata Y., Suzuki K., Matsuzaki H., Kawai M., Sekine Y., Tsuchiya K., Sugihara G., Suda S., Ouchi Y., Sugiyama T., Yoshikawa T., Mori N. Genetic analyses of the brain-derived neurotrophic factor (BDNF) gene in autism. Biochem Biophys Res Commun 2007, 356:200-206.
50. Patterson P.H. Maternal infection: window on neuroimmune interactions in fetal brain development and mental illness. Curr Opin Neurobiol 2002, 12:115-118.
51. Paxinos G., Franklin K.B.J. The mouse brain in stereotaxic coordinates 2001, Academic Press, New York, NY.
52. Perry E.K., Lee M.L., Martin-Ruiz C.M., Court J.A., Volsen S.G., Merrit J., Folly E., Iversen P.E., Bauman M.L., Perry R.H., Wenk G.L. Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain. Am J Psychiatry 2001, 158:1058-1066.
53. Purcell A.E., Jeon O.H., Zimmerman A.W., Blue M.E., Pevsner J. Postmortem brain abnormalities of the glutamate neurotransmitter system in autism. Neurology 2001, 57:1618-1628.
54. Raber J., Akana S.F., Bhatnagar S., Dallman M.F., Wong D., Mucke L. Hypothalamic-pituitary-adrenal dysfunction in Apoe(-/-) mice: possible role in behavioral and metabolic alterations. J Neurosci 2000, 20:2064-2071.
55. Rasalam A.D., Hailey H., Williams J.H., Moore S.J., Turnpenny P.D., Lloyd D.J., Dean J.C. Characteristics of fetal anticonvulsant syndrome associated autistic disorder. Dev Med Child Neurol 2005, 47:551-555.
56. Rinaldi T., Kulangara K., Antoniello K., Markram H. Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid. Proc Natl Acad Sci U S A 2007, 104:13501-13506.
57. Rinaldi T., Silberberg G., Markram H. Hyperconnectivity of local neocortical microcircuitry induced by prenatal exposure to valproic acid. Cereb Cortex 2008, 18:763-770.
58. Rodier P.M., Ingram J.L., Tisdale B., Croog V.J. Linking etiologies in humans and animal models: studies of autism. Reprod Toxicol 1997, 11:417-422.
59. Rodier P.M., Ingram J.L., Tisdale B., Nelson S., Romano J. Embryological origin for autism: developmental anomalies of the cranial nerve motor nuclei. J Comp Neurol 1996, 370:247-261.
60. Scaccianoce S., Del Bianco P., Paolone G., Caprioli D., Modafferi A.M., Nencini P., Badiani A. Social isolation selectively reduces hippocampal brain-derived neurotrophic factor without altering plasma corticosterone. Behav Brain Res 2006, 168:323-325.
61. Schneider T., Przewlocki R. Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Neuropsychopharmacology 2005, 30:80-89.
62. Schneider T., Roman A., Basta-Kaim A., Kubera M., Budziszewska B., Schneider K., Przewlocki R. Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid. Psychoneuroendocrinology 2008, 33:728-740.
63. Schneider T., Turczak J., Przewlocki R. Environmental enrichment reverses behavioral alterations in rats prenatally exposed to valproic acid: issues for a therapeutic approach in autism. Neuropsychopharmacology 2006, 31:36-46.
64. Schneider T., Ziolkowska B., Gieryk A., Tyminska A., Przewlocki R. Prenatal exposure to valproic acid disturbs the enkephalinergic system functioning, basal hedonic tone, and emotional responses in an animal model of autism. Psychopharmacology (Berl) 2007, 193:547-555.
65. Shah A., Oxley G., Lovic V., Fleming A.S. Effects of preweaning exposure to novel maternal odors on maternal responsiveness and selectivity in adulthood. Dev Psychobiol 2002, 41:187-196.
66. Stanton M.E., Peloso E., Brown K.L., Rodier P. Discrimination learning and reversal of the conditioned eyeblink reflex in a rodent model of autism. Behav Brain Res 2007, 176:133-140.
67. Terry L.M., Johanson I.B. Effects of altered olfactory experiences on the development of infant rats' responses to odors. Dev Psychobiol 1996, 29:353-377.
68. Tsujino N., Nakatani Y., Seki Y., Nakasato A., Nakamura M., Sugawara M., Arita H. Abnormality of circadian rhythm accompanied by an increase in frontal cortex serotonin in animal model of autism. Neurosci Res 2007, 57:289-295.
69. Wagner G.C., Reuhl K.R., Cheh M., McRae P., Halladay A.K. A new neurobehavioral model of autism in mice: pre- and postnatal exposure to sodium valproate. J Autism Dev Disord 2006, 36:779-793.
70. Watanabe M., Inoue Y., Sakimura K., Mishina M. Developmental changes in distribution of NMDA receptor channel subunit mRNAs. Neuroreport 1992, 3:1138-1140.
71. Whitfield H.J., Brady L.S., Smith M.A., Mamalaki E., Fox R.J., Herkenham M. Optimization of cRNA probe in situ hybridization methodology for localization of glucocorticoid receptor mRNA in rat brain: a detailed protocol. Cell Mol Neurobiol 1990, 10:145-157.
72. Wilson D.A., Sullivan R.M. Neurobiology of associative learning in the neonate: early olfactory learning. Behav Neural Biol 1994, 61:1-18.
73. Yasuda S., Liang M.H., Marinova Z., Yahyavi A., Chuang D.M. The mood stabilizers lithium and valproate selectively activate the promoter IV of brain-derived neurotrophic factor in neurons. Mol Psychiatry 2009, 14:51-59.
74. Yochum C.L., Dowling P., Reuhl K.R., Wagner G.C., Ming X. VPA-induced apoptosis and behavioral deficits in neonatal mice. Brain Res 2008, 1203:126-132.
75. Young R.L., Brewer N., Pattison C. Parental identification of early behavioural abnormalities in children with autistic disorder. Autism 2003, 7:125-143.
76. Zwaigenbaum L., Bryson S., Rogers T., Roberts W., Brian J., Szatmari P. Behavioral manifestations of autism in the first year of life. Int J Dev Neurosci 2005, 23:143-152.